General News
Jul. 28, 2016
Sequenom to be acquired by LabCorp for $301M
"Sequenom's market-leading NIPT (non-invasive pre-natal testing) and genetic testing capabilities will advance LabCorp's strategy to deliver world-class diagnostic solutions," Laboratory Corp. chairman and CEO David P. King said.




For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In